ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Pluri Inc

Pluri Inc (PLUR)

5.357
0.457
(9.33%)
Closed April 27 4:00PM
5.357
0.00
(0.00%)
After Hours: 5:03PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
5.357
Bid
4.62
Ask
6.08
Volume
6,889
4.73 Day's Range 5.44
3.4488 52 Week Range 8.56
Market Cap
Previous Close
4.90
Open
4.82
Last Trade
1
@
5.52
Last Trade Time
Financial Volume
$ 35,907
VWAP
5.2122
Average Volume (3m)
87,842
Shares Outstanding
41,480,172
Dividend Yield
-
PE Ratio
-7.85
Earnings Per Share (EPS)
-0.68
Revenue
287k
Net Profit
-28.32M

About Pluri Inc

Pluristem Therapeutics Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Nevada. Pluristem Therapeutics Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on June 30th. Th... Pluristem Therapeutics Inc is registered with the U.S. Security and Exchange Commission and incorporated in the state of Nevada. Pluristem Therapeutics Inc is primarely in the business of biological products (no diagnostic substances). For financial reporting, their fiscal year ends on June 30th. This page includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Pluristem Therapeutics Inc. Pluristem Therapeutics Inc is a US-based company which acts as a developer of placenta-based cell therapy product candidates for the treatment of multiple ischemic, inflammatory and hematologic conditions. The lead indications are critical limb ischemia, recovery after surgery for femoral neck fracture, and acute radiation syndrome. The company operations are focused on the research, development, clinical trials and manufacturing of cell therapeutics and related technologies. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Headquarters
Haifa, North, Isr
Founded
1970
Pluri Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker PLUR. The last closing price for Pluri was $4.90. Over the last year, Pluri shares have traded in a share price range of $ 3.4488 to $ 8.56.

Pluri currently has 41,480,172 shares outstanding. The market capitalization of Pluri is $222.33 million. Pluri has a price to earnings ratio (PE ratio) of -7.85.

PLUR Latest News

Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

Pluri’s patent enables mass-scale production of immune cell therapiesNew patented technology is applicable for the expansion of a variety of immune cellsTechnology sets stage for potential immune...

Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

HAIFA, Israel, March 28, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that...

Pluri Inc. Announces 1-for-8 Reverse Share Split

HAIFA, Israel, March 27, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) ("Pluri" or the “Company"), a leading biotechnology company that transforms cells into solutions, today...

Pluri’s Sustainable Cell-Based Coffee Addresses Critical Challenges Revealed in International Coffee Organization Market Report

International Coffee Organization (ICO) Market Report published on March 7, 2024 highlights alarming price instability challenging the coffee industryAccording to the report, adverse weather...

Engage with Pluri's Talent: Exciting Conference Appearances Ahead

HAIFA, Israel, March 19, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions that...

Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

HAIFA, Israel, March 14, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company"), a leading biotechnology company that transforms cells into solutions, today...

Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

HAIFA, Israel, March 11, 2024 (GLOBE NEWSWIRE) -- In a strategic move that underscores its innovative edge in the agtech sector, Pluri Inc. (Nasdaq:PLUR) (TASE:PLUR) ("Pluri" or "the Company...

Pluri Inc. Announces Appointment of Jim Roosevelt, Jr. to its Advisory Board

HAIFA, Israel, March 06, 2024 (GLOBE NEWSWIRE) -- Pluri Inc. (Nasdaq: PLUR) (TASE: PLUR) (“Pluri” or the “Company”), a leading biotech company that transforms cells into solutions that promote...

Pluri’s Innovation Across Various Industries: CEO Updates on Recent Achievements & 2024 Goals

Growing pipeline of industry-specific new potential products, services, collaborations and partnerships through PluriAgtech, PluriCDMO, PluriHealth, and PluriFoodRecent achievements include: new...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.3577.1455.514.73114505.11366352CS
4-0.343-6.017543859655.76.264.5578105.57079863CS
12-0.403-6.996527777785.768.484.5878426.70049868CS
261.561841.15198145033.79528.483.4488916525.71969463CS
52-2.563-32.36111111117.928.563.4488774265.76852289CS
156-2.643-33.0375811.57843.4488737806.47555683CS
260-2.643-33.0375811.57843.4488737806.47555683CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
BDRXBiodexa Pharmaceuticals PLC
$ 1.3254
(82.86%)
70.82M
IBRXImmunityBio Inc
$ 7.35
(43.84%)
40.28M
AGENAgenus Inc
$ 11.685
(40.78%)
3.37M
ULHUniversal Logistics Holdings Inc
$ 45.63
(38.74%)
484.22k
NIVFNewGenIvf Group Ltd
$ 1.77
(36.15%)
57.78M
MFImF International Ltd
$ 2.3153
(-77.82%)
21.23M
NWGLNature Wood Group Ltd
$ 5.05
(-70.03%)
2.48M
ICLKiClick Interactive Asia Group Ltd
$ 1.21
(-52.17%)
719.95k
NUWENewellis Inc
$ 0.1695
(-41.35%)
18.46M
SGBXSafe and Green Holdings Corporation
$ 0.1469
(-32.92%)
8.39M
PEGYPineapple Energy Inc
$ 0.065499
(26.20%)
325.57M
SQQQProShares UltraPro Short QQQ
$ 11.43
(-4.75%)
137.28M
INTCIntel Corporation
$ 31.88
(-9.20%)
119.84M
TSLATesla Inc
$ 168.29
(-1.11%)
109.84M
SOFISoFi Technologies Inc
$ 7.87
(3.69%)
88.63M

PLUR Discussion

View Posts
FDApproved FDApproved 5 days ago
Listen To What Yaky Says At The 3 Minute and 15 Second Point !!!

WOW !!! Ever After Foods Is Going BIG TIME !!!

👍️ 2
FDApproved FDApproved 1 week ago
FYI: TASE Is Closed On Monday & Tuesday.
👍️0
midastouch017 midastouch017 1 week ago
Too bad the entire market does
not appreciate PLURI's potential.
I thought i was the only one who
does not!
4.8420-0.2080 (-4.1188%)
As of 10:29AM EDT. Market open.
👍️0
sekander sekander 1 week ago
Wow. If things keep going like they're going, we're gonna need another
reverse split by the end of the year.
👍️0
FDApproved FDApproved 1 week ago
WOW !!! The Cow Has Left The Barn And Jumped Into Pluri's 3D Bioreactor !!!

In This Video Today, Yaky Says They, Being (Ever After Foods) Have Partnered With One Of The Largest Meat Producers In The World !!! That Puts Cargill & JBS At The Top Of the List !!! WOW !!!

👍️ 2
sekander sekander 1 week ago
I am very well able to grasp the thinly veiled scam that is this company.
Potential? HAH! After 10 years, one has to wonder if there is any real
intent to do anything. Projects come and projects go but nothing is ever
seen to conclusion. Just a lot of pie in the sky rhapsodizing meant to draw
in the next batch of suckers. If they didn't do reverse splits, you'd need a
microscope to find the share price.
👍️ 1
FDApproved FDApproved 1 week ago
You Never Will Be Able To Grasp/Understand Pluri's Technology & Potential !!!

That's Okay, As We Love Sideline Sally's With Their Beautiful Pom Poms !!!
👍️ 1
sekander sekander 1 week ago
New board, same garbage stock.
The endless death spiral continues. You can try changing your name but a leopard can't change his spots.
This leopard/turkey is headed straight for the dumpster. Still not one positive indicator in 10 years.
👍️0
TrendTrade2016 TrendTrade2016 2 weeks ago
PLUR...POST SPLITY BOOM IN PLACE
👍️ 2
midastouch017 midastouch017 3 weeks ago
Very warm market reaction towards the news!
👍️0
FDApproved FDApproved 3 weeks ago
Breakthrough in Immune Cell Expansion: Pluri Granted U.S Patent for New Method

https://markets.businessinsider.com/news/stocks/breakthrough-in-immune-cell-expansion-pluri-granted-u-s-patent-for-new-method-1033229167
👍️ 2
midastouch017 midastouch017 3 weeks ago
And with it you also have no business!

5.29-0.13 (-2.40%)
As of 01:25PM EDT. Market open.
Volume 571,492
Avg. Volume 17,671

When will you learn, a patent is only worthwhile
if and when someone pays you to make use of it.
👍️0
midastouch017 midastouch017 3 weeks ago
After 3 consecutive r/s i wonder how much
wisdom i can achieve from a dry prune that
you are!
👍️ 1
FDApproved FDApproved 3 weeks ago
And Without It You Have No Business !!! You Have Much To Learn Grasshopper !!!
👍️ 2
midastouch017 midastouch017 3 weeks ago
A patent is only a patent.
I wager besides the immediate frenzy,
stock will end at no more than +5% from
closing day Friday!
👍️0
FDApproved FDApproved 3 weeks ago
Pluri Biotech Is In The Driver's Seat Now !!!

I Hear Big Pharma Knocking At The Door !!!

https://www.globenewswire.com/news-release/2024/04/08/2859054/11974/en/Breakthrough-in-Immune-Cell-Expansion-Pluri-Granted-U-S-Patent-for-New-Method.html
👍️ 2
FDApproved FDApproved 3 weeks ago
WOW !!!

https://www.marketscreener.com/quote/stock/PLURI-INC-62637874/news/Breakthrough-in-Immune-Cell-Expansion-Pluri-Granted-U-S-Patent-for-New-Method-46385901/
👍️ 2
FDApproved FDApproved 4 weeks ago
Pluri™ Receives First-Ever Patent Approval for 3D Bioreactor Technology in Plant Cell Cultivation

https://pluri-biotech.com/wp-content/uploads/2024/03/1710196121_1710148623_Pluri_PR_re._Plant_Cell_Culturing_Patent_FINAL_FOR_RELEASE.pdf
👍️ 2
FDApproved FDApproved 4 weeks ago
Pluri Selected as CDMO by Remedy Cell for Cell-Derived Cell-Free Drug Manufacturing

https://pluri-biotech.com/wp-content/uploads/2024/03/1710397832_1710357602_Pluri_CDMO_press_release_FINAL_FOR_RELEASE.pdf
👍️ 2
FDApproved FDApproved 4 weeks ago
Pluri Launches Advanced Global Cell Therapy Contract Development and Manufacturing Organization

https://pluri-biotech.com/wp-content/uploads/2024/01/1704687167_1704639961_CDMO_PR_FINAL_FOR_RELEASE.pdf
👍️ 2
FDApproved FDApproved 4 weeks ago
Pluri and Bar-Ilan University to Develop PLX Cells for the Treatment of Cocaine Addiction

https://pluri-biotech.com/wp-content/uploads/2023/12/1703156443_1703151841_Pluri_and_Bar_Ilan_University_FINAL.pdf
👍️ 2
FDApproved FDApproved 4 weeks ago
Step into the Future: Pluri Launches Sustainable Cell-Based Coffee as Countermeasure for Global Coffee Crisis

https://pluri-biotech.com/wp-content/uploads/2024/01/1705993672_Pluri_PR_Coffee_Launch_FINAL_FOR_RELEASE.pdf
👍️ 2
FDApproved FDApproved 4 weeks ago
Israeli startup Ever After Foods addresses ‘critical scaling challenge’ in cultivated meat: ‘We have a huge cost advantage’

https://agfundernews.com/ever-after-foods-addresses-critical-scaling-challenge-in-cultivated-meat#:~:text=He%20added%3A%20%E2%80%9CAn%20Ever%20After,have%20a%20huge%20cost%20advantage.%E2%80%9D
👍️ 2
FDApproved FDApproved 4 weeks ago
Pluri Is At 3 Conferences The Week Of April 8th !!!

https://pluri-biotech.com/media-events-events/
👍️ 2
FDApproved FDApproved 4 weeks ago
Pluri’s Business Verticals Gain Traction in Global Markets; Leadership to Participate and Present in Upcoming Conferences

https://pluri-biotech.com/wp-content/uploads/2024/03/1711621213_1711614542_Pluri_PR_re_Conferences_FINAL_FOR_RELEASE.pdf
👍️ 2

Your Recent History

Delayed Upgrade Clock